Apreo Health

Apreo Health is redefining interventional pulmonology with a non-destructive, tissue-sparing solution for severe emphysema—one of the least treated and most misunderstood diseases in medicine. Apreo, founded at The Foundry, one of the world’s leading medical technology incubators, and backed by top-tier investors, is led by a team with deep expertise in pulmonology and medical device innovation. The company is advancing a dedicated therapy designed to expand accessibility, simplify delivery, and transform the treatment paradigm for patients with severe emphysema.